Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Christophe, Sajous"'
Autor:
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, Marie Attard, Claire Bournaud, Ludovic Lacroix, Danielle Benisvy, David Taïeb, Stéphane Bardet, Marie Terroir-Cassou-Mounat, Nadège Anizan, Emilie Bouvier-Morel, Livia Lamartina, Georges Lion, Sarah Betrian, Christophe Sajous, Aurélie Schiazza, Marie-Eve Garcia, Renaud Ciappuccini, Martin Schlumberger, Abir Al Ghuzlan, Yann Godbert, Isabelle Borget
Publikováno v:
Clinical Cancer Research. :OF1-OF9
Purpose: To evaluate the efficacy and safety of dabrafenib-trametinib-131I for the treatment of radioactive iodine refractory metastatic differentiated thyroid cancer (DTC) with a BRAF p.V600E mutation. Patients and Methods: A prospective phase II tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90b1a9690ff12239a90cfbd03e7079a7
https://doi.org/10.1158/1078-0432.ccr-23-0046
https://doi.org/10.1158/1078-0432.ccr-23-0046
Autor:
Emeline, Colomba, Jérôme, Alexandre, Gwénaël, Le Teuff, Catherine, Genestie, Dahna, Coupez, Isabelle Ray, Coquard, Pierre Emmanuel, Brachet, Sixtine, de Percin, Christophe, Sajous, Michel, Fabbro, Nicolas, Delanoy, Florence, Joly, Jean Sebastien, Frenel, Patricia, Pautier, Alexandra, Leary
Publikováno v:
Gynecologic Oncology. 169:78-84
Around 15% of metastatic endometrial carcinoma (EC) are MMRd/MSI-H improving response to immune checkpoint inhibitors (ICI). So far, few data existed considering the chemotherapy (CT) sensitivity in MMRd/MSI-H EC, especially response to first-line pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e1dcbaa6573f8d88a27ec68f4eef1c
https://doi.org/10.1016/j.ygyno.2022.11.029
https://doi.org/10.1016/j.ygyno.2022.11.029
Autor:
Isabelle Borget, Yann Godbert, Abir Al Ghuzlan, Martin Schlumberger, Renaud Ciappuccini, Marie-Eve Garcia, Aurélie Schiazza, Christophe Sajous, Sarah Betrian, Georges Lion, Livia Lamartina, Emilie Bouvier-Morel, Nadège Anizan, Marie Terroir-Cassou-Mounat, Stéphane Bardet, David Taïeb, Danielle Benisvy, Ludovic Lacroix, Claire Bournaud, Marie Attard, Slimane Zerdoud, Christine Do Cao, Sophie Leboulleux
Waterfall plot of the RECIST response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e3eaa0b6330cd379842c7c5137e8ea
https://doi.org/10.1158/1078-0432.22802202
https://doi.org/10.1158/1078-0432.22802202
Autor:
Isabelle Borget, Yann Godbert, Abir Al Ghuzlan, Martin Schlumberger, Renaud Ciappuccini, Marie-Eve Garcia, Aurélie Schiazza, Christophe Sajous, Sarah Betrian, Georges Lion, Livia Lamartina, Emilie Bouvier-Morel, Nadège Anizan, Marie Terroir-Cassou-Mounat, Stéphane Bardet, David Taïeb, Danielle Benisvy, Ludovic Lacroix, Claire Bournaud, Marie Attard, Slimane Zerdoud, Christine Do Cao, Sophie Leboulleux
Quality of Life scores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00fe0c348e48c5bdad907fbc79d2bfc3
https://doi.org/10.1158/1078-0432.22802181
https://doi.org/10.1158/1078-0432.22802181
Autor:
Isabelle Borget, Yann Godbert, Abir Al Ghuzlan, Martin Schlumberger, Renaud Ciappuccini, Marie-Eve Garcia, Aurélie Schiazza, Christophe Sajous, Sarah Betrian, Georges Lion, Livia Lamartina, Emilie Bouvier-Morel, Nadège Anizan, Marie Terroir-Cassou-Mounat, Stéphane Bardet, David Taïeb, Danielle Benisvy, Ludovic Lacroix, Claire Bournaud, Marie Attard, Slimane Zerdoud, Christine Do Cao, Sophie Leboulleux
Purpose:To evaluate the efficacy and safety of dabrafenib-trametinib-131I for the treatment of radioactive iodine refractory metastatic differentiated thyroid cancer (DTC) with a BRAF p.V600E mutation.Patients and Methods:A prospective phase II trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0760c40119c9bcea6f93263a41ec25f
https://doi.org/10.1158/1078-0432.c.6641715
https://doi.org/10.1158/1078-0432.c.6641715
Autor:
Freyer, Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, Sara Calattini, Stéphanie Cartalat, Marion Chauvenet, Marc Colombel, Stéphane Dalle, Tristan Dagonneau, Marie Darrason, Gilles Devouassoux, Michaël Duruisseaux, Marielle Guillet, Olivier Glehen, Pierre Philouze, François Tronc, Thomas Walter, Benoît You, Gilles
Publikováno v:
Cancers; Volume 14; Issue 1; Pages: 29
This article presents the protective measures put in place at the “Institut de Cancérologie des Hospices de Lyon” (IC-HCL) during the first wave of the COVID-19 pandemic in France (spring 2020) and how they impacted IC-HCL clinical activity. Spr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::59eea606975723824a9b7db77bdd694b
Autor:
Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, Sara Calattini, Stéphanie Cartalat, Marion Chauvenet, Marc Colombel, Stéphane Dalle, Tristan Dagonneau, Marie Darrason, Gilles Devouassoux, Michaël Duruisseaux, Marielle Guillet, Olivier Glehen, Pierre Philouze, François Tronc, Thomas Walter, Benoît You, Gilles Freyer
Publikováno v:
Cancers
Cancers, Vol 14, Iss 29, p 29 (2022)
Cancers, Vol 14, Iss 29, p 29 (2022)
Simple Summary This article presents the protective measures put in place at the “Institut de Cancérologie des Hospices de Lyon” (IC-HCL) during the first wave of the COVID-19 pandemic in France (spring 2020) and how they impacted IC-HCL clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::04d7cddd901cbf2d97ee06a09cb56bd2
http://europepmc.org/articles/PMC8750524
http://europepmc.org/articles/PMC8750524
Autor:
Vlaeminck-Guillem, Denis Maillet, Nathalie Allioli, Julien Péron, Adriana Plesa, Myriam Decaussin-Petrucci, Sophie Tartas, Christophe Sajous, Alain Ruffion, Sébastien Crouzet, Gilles Freyer, Virginie
Publikováno v:
Cancers; Volume 13; Issue 23; Pages: 6014
HER2-dependent signaling may support the development of metastatic castration-resistant prostate cancer (mCRPC) by activating androgen receptor signaling through ligand-independent mechanisms. From 41 mCRPC patients (including 31 treated with Androge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::f57f4c421299b8746201d90934ca6883
Autor:
Denis Maillet, Nathalie Allioli, Julien Péron, Adriana Plesa, Myriam Decaussin-Petrucci, Sophie Tartas, Christophe Sajous, Alain Ruffion, Sébastien Crouzet, Gilles Freyer, Virginie Vlaeminck-Guillem
Publikováno v:
Cancers
Cancers, Vol 13, Iss 6014, p 6014 (2021)
Cancers, Vol 13, Iss 6014, p 6014 (2021)
Simple Summary Although the role of HER2 in prostate cancer remains controversial, HER2 can be overexpressed during prostate cancer progression. In this study, we prospectively isolated circulating tumor cells (CTCs) from 41 men with metastatic castr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::30b88dece5b40cbb127abbc4aeaaf88b
http://europepmc.org/articles/PMC8656805
http://europepmc.org/articles/PMC8656805
Autor:
Thibaut Reverdy, Solene De Talhouet, Gilles Freyer, Christophe Sajous, Benoit You, Julien Péron, Romain Varnier, Colette Smentek
Publikováno v:
Cancers
Cancers, Vol 13, Iss 4840, p 4840 (2021)
Cancers, Vol 13, Iss 4840, p 4840 (2021)
Simple Summary Gene expression signatures were initially developed to take into account tumor biology for adjuvant chemotherapy decision and have become a standard option in hormone receptors-positive/HER2-negative early breast cancer. While recent r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc675d271c60312f211a25da9e81b41
http://europepmc.org/articles/PMC8508256
http://europepmc.org/articles/PMC8508256